Avai Bio EBITDA Growth & History (AVAI)

Avai Bio's calculated EBITDA was −$1.7M for fiscal 2026.

View full Avai Bio company overview

Avai Bio annual ebitda history

Avai Bio annual ebitda

Fiscal yearPeriod endedEBITDAChangeGrowth
20262026-03-31−$1.7M−$655,644
20252025-03-31−$1.1M$983,727
20242024-03-31−$2.1M−$1.7M
20232023-03-31−$325,516−$434,211
20202020-03-31$108,695$182,118
20192019-03-31−$73,423

Avai Bio ebitda trends

Over the last five reported fiscal years, Avai Bio's ebitda decreased from −$73,423 to −$1.7M, a change of −$1.7M. The latest reported quarter, Q1 2027, shows −$546,797.

About the metric

What EBITDA means

EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.

Calculation and source

How TickerStat calculates EBITDA

TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Avai Bio filings at SEC.gov ↗